“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

The Department of Public Health and Social Services encourages proactive approach to protect oneself and others from health ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

Find out whether you should get the RSV vaccine, known as Abrysvo, during pregnancy and when it's recommended.

Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new ...

The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...

FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

RFK Jr. has eliminated the expert advisory committee on vaccines. Without expert guidance, we may see more frequent and ...

More than 14 million children around the world have not received a single dose of any vaccine, according to new data from the World Health Organization and UNICEF.

In June, infectious disease physicians sounded the alarm over the Trump administration overstepping existing, transparent processes for changing vaccine recommendations, particularly pointing to new ...